Voyager Therapeutics, Inc.
Total Trades
75
Buys
2
Sells
65
Largest Trade
N/A
Insiders
14
Institutional Funds
91
Inst. Value
$1M+
Activist Filings
23
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Swartz Robin | COO & CBO | SELL | $15K–$50K | 6K | $3.77 | Feb 26, 2026 |
| Sandrock Alfred | President and CEO | SELL | $50K–$100K | 14K | $3.79 | Feb 26, 2026 |
| Jorgensen Nathan D. | CFO | SELL | $15K–$50K | 5K | $3.77 | Feb 26, 2026 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $15K–$50K | 4K | $3.76 | Feb 26, 2026 |
| Swartz Robin | COO & CBO | SELL | $1K–$15K | 4K | $3.44 | Feb 20, 2026 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $1K–$15K | 3K | $3.44 | Feb 20, 2026 |
| Sandrock Alfred | President and CEO | SELL | $15K–$50K | 12K | $3.41 | Feb 20, 2026 |
| Swartz Robin | COO & CBO | SELL | $15K–$50K | 5K | $3.85 | Feb 11, 2026 |
| Sandrock Alfred | President and CEO | SELL | $15K–$50K | 12K | $3.78 | Feb 11, 2026 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $1K–$15K | 4K | $3.85 | Feb 11, 2026 |
| Ferguson Toby | Chief Medical Offi… | SELL | $15K–$50K | 10K | $3.43 | Apr 4, 2025 |
| Sandrock Alfred | President and CEO | SELL | $15K–$50K | 11K | $3.43 | Apr 4, 2025 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $1K–$15K | 3K | $4.26 | Feb 24, 2025 |
| Carter Todd Alfred | Chief Scientific O… | GRANT | N/A | 46K | — | Feb 24, 2025 |
| Sandrock Alfred | President and CEO | GRANT | N/A | 145K | — | Feb 24, 2025 |
| Sandrock Alfred | President and CEO | SELL | $15K–$50K | 12K | $4.24 | Feb 24, 2025 |
| Swartz Robin | COO & CBO | GRANT | N/A | 71K | — | Feb 24, 2025 |
| Swartz Robin | COO & CBO | SELL | $15K–$50K | 4K | $4.25 | Feb 24, 2025 |
| Swartz Robin | COO & CBO | SELL | $15K–$50K | 3K | $5.09 | Jan 15, 2025 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $1K–$15K | 1K | $5.13 | Jan 15, 2025 |
| Swartz Robin | COO&CBO | SELL | $15K–$50K | 7K | $5.65 | Dec 26, 2024 |
| Fahey Sandell Jacquelyn | Chief Legal Officer | SELL | $15K–$50K | 6K | $5.82 | Oct 3, 2024 |
| Swartz Robin | COO | SELL | $1K–$15K | 1K | $9.88 | Apr 3, 2024 |
| Sandrock Alfred | President and CEO | SELL | $100K–$500K | 12K | $9.86 | Apr 3, 2024 |
| Swartz Robin | COO | SELL | $15K–$50K | 4K | $7.45 | Feb 22, 2024 |
| Sandrock Alfred | President and CEO | SELL | $50K–$100K | 13K | $7.46 | Feb 22, 2024 |
| PFREUNDSCHUH PETER P. | CFO | SELL | $15K–$50K | 4K | $7.46 | Feb 22, 2024 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $15K–$50K | 4K | $7.50 | Feb 22, 2024 |
| Swartz Robin | COO | SELL | $15K–$50K | 3K | $7.15 | Jan 19, 2024 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $1K–$15K | 1K | $7.18 | Jan 19, 2024 |
| PFREUNDSCHUH PETER P. | CFO | SELL | $50K–$100K | 14K | $6.99 | Oct 5, 2023 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $50K–$100K | 11K | $8.16 | Sep 18, 2023 |
| Carter Todd Alfred | Chief Scientific O… | EXERCISE | $1K–$15K | 5K | $2.85 | Sep 18, 2023 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $50K–$100K | 6K | $10.80 | Jul 10, 2023 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $50K–$100K | 5K | $11.41 | Jul 5, 2023 |
| Carter Todd Alfred | Chief Scientific O… | EXERCISE | $1K–$15K | 5K | $2.85 | Jul 5, 2023 |
| Sandrock Alfred | President and CEO | SELL | $50K–$100K | 7K | $7.83 | Apr 5, 2023 |
| Swartz Robin | COO | SELL | $1K–$15K | 1K | $7.83 | Apr 5, 2023 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $15K–$50K | 2K | $7.76 | Mar 22, 2023 |
| Swartz Robin | COO | SELL | $15K–$50K | 4K | $7.76 | Mar 22, 2023 |
| Hesslein Robert W. | Senior VP & Genera… | SELL | $15K–$50K | 4K | $7.76 | Mar 22, 2023 |
| Swartz Robin | COO | SELL | $100K–$500K | 15K | $8.20 | Mar 17, 2023 |
| NEUROCRINE BIOSCIENCES INC | 10% Owner | BUY | $1M+ | 4.4M | $8.88 | Feb 24, 2023 |
| Hesslein Robert W. | Senior VP & Genera… | SELL | $15K–$50K | 3K | $7.45 | Feb 23, 2023 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $1K–$15K | 738 | $7.45 | Feb 23, 2023 |
| Carter Todd Alfred | Chief Scientific O… | GRANT | N/A | 34K | — | Feb 23, 2023 |
| Carter Todd Alfred | Chief Scientific O… | SELL | $1K–$15K | 797 | $7.67 | Feb 15, 2023 |
| Hesslein Robert W. | Senior VP & Genera… | SELL | $15K–$50K | 3K | $7.67 | Feb 15, 2023 |
| Third Rock Ventures III, L.P. | 10% Owner | SELL | $1M+ | 389K | $9.23 | Feb 2, 2023 |
| Third Rock Ventures III, L.P. | 10% Owner | SELL | $100K–$500K | 50K | $9.02 | Jan 31, 2023 |
Institutional Ownership
13F filings as of Dec 31, 2025 · 91 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| Erste Asset Management GmbH | 1.2M | $1M+ | SH |
| DIMENSIONAL FUND ADVISORS LP | 1.1M | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 983K | $1M+ | SH |
| STATE STREET CORP | 936K | $1M+ | SH |
| SPHERA FUNDS MANAGEMENT LTD. | 340K | $1M+ | SH |
| FIDUCIARY TRUST CO | 334K | $1M+ | SH |
| VANGUARD GROUP INC | 299K | $1M+ | SH |
| RENAISSANCE TECHNOLOGIES LLC | 296K | $1M+ | SH |
| UBS Group AG | 219K | $500K+ | SH |
| BARCLAYS PLC | 162K | $500K+ | SH |
| AMERICAN CENTURY COMPANIES INC | 150K | $500K+ | SH |
| JANE STREET GROUP, LLC | 145K | $500K+ | SH |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 138K | $500K+ | SH |
| GOLDMAN SACHS GROUP INC | 110K | $100K–$500K | SH |
| Patriot Financial Group Insurance Agency, LLC | 103K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 100K | $100K–$500K | SH |
| Point72 Asset Management, L.P. | 95K | $100K–$500K | SH |
| Privium Fund Management B.V. | 95K | $100K–$500K | SH |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 92K | $100K–$500K | SH |
| OMERS ADMINISTRATION Corp | 83K | $100K–$500K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 18, 2026
7.2%
4.0M shares
SC 13G/A · Feb 17, 2026
6.8%
4.0M shares
Integrated Core Strategies (US) LLC
SC 13G · Jan 26, 2026
6.0%
3.3M shares
SC 13G/A · Nov 14, 2025
7.6%
4.2M shares
SC 13G/A · Nov 14, 2025
6.8%
4.0M shares
SC 13G/A · May 15, 2025
9.8%
5.4M shares
SC 13G/A · Apr 24, 2025
6.4%
3.5M shares
SC 13G/A · Feb 14, 2025
9.9%
5.4M shares
SC 13G/A · Nov 14, 2024
10.0%
5.6M shares
SC 13G/A · Nov 14, 2024
9.5%
5.2M shares
SC 13G/A · Aug 7, 2024
10.0%
5.5M shares
SC 13G/A · Feb 14, 2024
0.0%
0 shares
SC 13G/A · Feb 14, 2024
9.6%
4.2M shares
The Vanguard Group - 23-1945930
SC 13G/A · Feb 13, 2024
5.8%
2.5M shares
SC 13G · Jan 29, 2024
6.0%
2.6M shares
SC 13D/A · Feb 24, 2023
19.9%
8.6M shares
SC 13G/A · Feb 14, 2023
14.1%
5.4M shares
SC 13G · Feb 14, 2023
8.8%
3.4M shares
SC 13G/A · Jan 13, 2023
10.0%
3.9M shares
SC 13G/A · Apr 26, 2022
11.1%
4.3M shares
SC 13G/A · Feb 15, 2022
0.0%
0 shares
SC 13G/A · Feb 14, 2022
9.4%
3.6M shares
SC 13G/A · Feb 11, 2022
0.0%
0 shares